However, the difference between sorafenib and lenvatinib failed to reach statistical significance ( P =0.190).
← all excerpts
Role of transarterial chemoembolization for hepatocellular carcinoma with extrahepatic metastases in the era of advancing systemic therapy.
1
0.1900
0.1900